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Kidneys with heavy proteinuria show fibrosis, inflammation,
and oxidative stress, but no tubular phenotypic change
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Kidneys with heavy proteinuria show fibrosis, inflammation,
and oxidative stress, but no tubular phenotypic change.
Background. Sustained proteinuria is a major factor lead-
ing to kidney fibrosis and end-stage renal failure. Tubular ep-
ithelial cells are believed to play a crucial role in this process
by producing mediators leading to fibrosis and inflammation.
Congenital nephrotic syndrome of the Finnish type (NPHS1)
is a genetic disease caused by mutations in a podocyte protein
nephrin, which leads to constant heavy proteinuria from birth.
In this work we studied the tubulointerstitial changes that occur
in NPHS1 kidneys during infancy.
Methods. The pathologic lesions and expression of profibrotic
and proinflammatory factors in nephrectomized NPHS1 kid-
neys were studied by immunohistochemistry, Western blotting,
and cytokine antibody array. Oxidative stress in kidneys was
assessed by measurement of gluthatione redox state.
Results. The results indicated that (1) severe tubulointerstitial
lesions developed in NPHS1 kidneys during infancy; (2) tubu-
lar epithelial cells did not show transition into myofibroblasts as
studied by the expression of vimentin, a-smooth muscle actin
(a-SMA), collagen, and matrix metalloproteinases 2 and 9
(MMP-2 and -9); (3) the most abundant chemokines in
NPHS1 tissue were neutrophil activating protein-2 (NAP-2),
macrophage inhibiting factor (MIF), and monocyte chemoat-
tractant protein-1 (MCP-1); (4) monocyte/macrophage cells
expressing CD14 antigen were the major inflammatory cells
invading the interstitium; (5) the arteries and arterioles showed
intimal hypertrophy, but the microvasculature in NPHS1 kid-
neys remained quite normal; and (6) excessive oxidative stress
was evident in NPHS1 kidneys.
Conclusion. Heavy proteinuria in NPHS1 kidneys was associ-
ated with interstitial fibrosis, inflammation, and oxidative stress.
The tubular epithelial cells, however, were resistant to protein-
uria and did not show epithelial-mesenchymal transition.
Sustained heavy proteinuria is believed to lead to pro-
gressive kidney damage [1]. High urinary protein con-
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tent may elicit proinflammatory and profibrotic effects
that contribute to chronic tubulointerstitial damage and
loss of renal function [2]. Several in vitro studies have
demonstrated that urinary proteins stimulate tubular ep-
ithelial cells to secrete factors, such as monocyte chemoat-
tractant protein-1 (MCP-1), that promote inflammation
[3]. This is associated with an influx of inflammatory
cells to interstitium as well as activation and prolifera-
tion of interstitial fibroblasts. The major profibrotic fac-
tor implicated in this process is transforming growth
factor-b (TGF-b) [4]. Tubular epithelial cells can also di-
rectly promote fibrosis by producing extracellular ma-
trix (ECM) components. Tubular epithelial cells may
undergo epithelial-mesenchymal transition (EMT) into
myofibroblasts, which may invade interstitium [5]. With
increased fibrosis and inflammation the number of func-
tioning nephrons progressively declines and renal failure
ensues.
The data on the pathophysiologic lesions caused by
proteinuria are mainly based on animal models and cell
culture studies. In this work we evaluated the tubulointer-
stitial changes in kidneys with congenital nephrotic syn-
drome of the Finnish type (CNF, NPHS1). NPHS1 is a
recessively inherited renal disease caused by mutations
in the nephrin gene [6]. Nephrin is a podocyte-specific
protein located at the slit diaphragm of kidney glomeru-
lus. The two most common mutations in the nephrin gene,
Fin-major and Fin-minor, lead to a severe disorder char-
acterized by lack of nephrin in the kidney glomerulus
and massive proteinuria (up to 100 g/L) starting already
during the fetal period [7]. Children with NPHS1 are
nephrectomized as infants and their kidneys serve as a
unique material for studying the consequences of contin-
uous, heavy proteinuria. Since the basic defect in NPHS1
only affects the glomerular filter, all tubulointerstitial le-
sions observed are secondary to the protein leakage.
In this work, we used immunohistochemistry, Western
blotting, cytokine array, and glutathione analysis to eval-
uate the nature of the tubulointerstitial lesions, possible
changes in tubular epithelial cell phenotype, cortical cy-
tokine production, and oxidative state in NPHS1 kidneys.
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METHODS
Tissue samples
A total of 52 kidneys were nephrectomized from chil-
dren with NPHS1 between 1986 and 2003. The age of the
patients at the time of nephrectomy ranged from 4 to 44
months. Before nephrectomy these children were treated
with daily albumin infusions to supplement the continu-
ous heavy proteinuria. Routine formalin-fixed paraffin-
embedded samples were taken from the kidneys and the
rest of the renal cortex was snap-frozen in liquid nitrogen
and stored at −70◦C.
As controls we used eight normal adult kidneys (age 47
to 58 years) removed for transplantation. These kidneys
had proved unsuitable for transplantation mainly be-
cause of vascular abnormalities. Formalin-fixed paraffin-
embedded sections and snap-frozen samples were
collected. The cadaver kidneys had to be used as controls,
since fresh tissue samples from normal infant kidneys
were not possible to obtain. In the cytokine array, porcine
kidney samples were used as additional controls, since
brain death may affect the cytokine expression. Porcine
kidney samples were obtained from two newborns and
one 6-month-old pig. They were snap-frozen and stored
at −70◦C.
The study protocol was approved by the ethical com-
mittee of the Hospital for Children and Adolescents of
the University of Helsinki.
Antibodies
The following antibodies were purchased from Dako-
Cytomation (Glostrup, Denmark): CD20cy (M0755),
CD68 (M0876), pan-Ig (against IgA, IgG, and IgM)
(P0212), a-smooth muscle actin (a-SMA) (M0851), and
vimentin (M7020). Antibodies acquired from Santa Cruz
Biotechnology (Santa Cruz, CA, USA) were heat shock
protein 27 (HSP27) (sc-1048), NAP-2 (sc-19224), pan-
cytokeratin (sc-8018), megalin (sc-16476), TGF-b1 (sc-
146), HSP27 (sc-1048) and vascular endothelial growth
factor (VEGF) (sc-7269). Antibodies against CD3
(ab828), CD14 (ab8679), and collagen type I (ab6308)
were bought from Abcam (Cambridge, Cambridgeshire,
UK). Anticollagen type VI (MAB3303) was bought from
Chemicon International (Temecula, CA, USA), and anti-
CD13 (MS-1079-S) and anti-myeloperoxidase (MPO)
(RB-373-A) from NeoMarkers (Fremont, CA, USA).
In addition we had two anti-MCP-1 antibodies: ALX-
804–465 from Alexis Biochemicals (Lausen, Switzerland)
and AF-279-NA from R&D Systems (Minneapolis, MN,
USA). All these primary antibodies were unconjugated,
except for horseradish peroxidase (HRP)-conjugated
pan-Ig antibodies, and the dilutions used ranged from
1:10 to 1:250 in immunohistochemistry and from 1:1000
to 1:3000 in Western blotting.
We used the following markers for different cell types:
CD13 for monocytes, CD68 for macrophages, CD14 for
monocytes and macrophages and some of their subpop-
ulations, MPO for granulocytes and monocytes, CD3
for T lymphocytes, CD20cy for B lymphocytes, mast
cell tryptase (MCT) for activated mast cells and pan-
immunoglobulin (pan-Ig) antibody for immunoglobulin
producing plasma cells.
Light microscopy
The histologic lesions in NPHS1 kidneys were evalu-
ated by light microscopy from paraffin-embedded tissue
sections stained with hematoxylin and eosin or periodic
acid silver methenamin (PASM). In order to quantitate
the changes, interstitial fibrosis, inflammatory cells, tubu-
lar cysts, and glomerular sclerosis were graded from 0 to
3. The total histologic score was the sum of these values
and ranged from 0 (normal) to 12 (severely damaged).
The samples were scored independently by two experi-
enced renal pathologists.
Immunohistochemistry
For the immunofluorescence stainings, the cryosec-
tions (5 lm) of the kidney samples were fixed with 3.5%
paraformaldehyde or acetone, depending on the anti-
body used. The stainings were performed in a traditional
way. Sections used as negative control were incubated
in phosphate-buffered saline (PBS) instead of a primary
antibody.
Immunoperoxidase stainings were performed on the
sections of formalin-fixed, paraffin-embedded renal sam-
ples in a conventional way. To improve antibody pene-
tration, microwave treatment in 10 mmol/L citric acid for
10 minutes was performed or Dako Target Retrieval Solu-
tion (S1699) (DakoCytomation) was used depending on
the antibody. Amplification of the primary antibody reac-
tion was achieved by incubating the sections with biotiny-
lated secondary antibody (Vector Elite ABC Kit) (Vector
Laboratories Inc., Burlingame, CA, USA). Immunoper-
oxidase staining of cryosections was performed similarly.
The sections were fixed with 3.5% paraformaldehyde or
acetone depending on the antibody used.
Light microscopy was performed with a standard Le-
ica DM RX light microscope equipped with an Olympus
DP70 digital camera. To calculate the area fraction of a
particular immunostained component images were im-
ported to the freeware image analysis program NIH Im-
ageJ 1.32j (National Institutes of Health, Bethesda, MD,
USA). Sequential gray-scale images were grabbed using
the ×10 objective. The presence of glomeruli in the fields
was ignored and a threshold was applied to each image
at a constant level that distinguished between the stained
component and the background. The proportion of black
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to white pixels in the image was then calculated as a per-
centage [8].
All immunohistochemical data presented were ana-
lyzed from at least four control and six NPHS1 kidneys.
Western blotting
Tissue samples of kidney cortex were homogenized
with Ultra-Turrax (Rose Scientific Ltd., Alberta, Canada)
in Laemmli sample buffer, and the proteins were sep-
arated on a gel (8% to 12%) and blotted onto an
Immobilon-P polyvinylidene fluoride (PVDF) mem-
brane (Millipore, Billerica, MA, USA). After blocking
with 5% nonfat dry milk in PBS, the membrane was
stained with a primary antibody followed by a peroxidase-
conjugated secondary antibody (Jackson ImmunoRe-
search, West Grove, PA, USA). Bound antibodies were
visualized using enhanced chemiluminescence (ECL)
(Amersham Biosciences, Uppsala, Sweden).
Cytokine array
Custom human cytokine antibody array (RayBiotech
Inc., Atlanta, GA, USA) consisted of 50 different cy-
tokine and chemokine antibodies spotted in duplicate
onto a membrane [9]. The experiments were performed
according to manufacturer’s instructions. Briefly, tissue
samples of kidney cortex were homogenized in lysis
buffer, centrifuged at 14,000 rpm for 10 minutes. The
protein concentration was measured using DC Protein
Assay (Bio-Rad, Hercules, CA, USA). Membranes were
incubated with blocking buffer, 500 lg of tissue lysate
was added to the membrane and incubated over night at
4◦C. After washes, membranes were incubated with bi-
otinylated antibody for 2 hours, washed, and incubated
for 1 hour with HRP-conjugated streptavidin. Unbound
reagents were washed, and the membranes were devel-
oped with the ECL system (Amersham Biosciences).
Chemiluminescence was quantified with Scion Image
Beta 4.02 Win analysis software. The results were ex-
pressed as relative signal intensities so that positive
control spots included in each membrane were given an
intensity value of 100.
Terminal deoxynucleotidyl transferase (TdT)-mediated
deoxyuridine triphosphate (dUTP) nick end
labeling (TUNEL)
The occurrence of apoptosis in kidney tubules was an-
alyzed by monitoring the presence of DNA fragmenta-
tion [10]. Slides were analyzed by conventional light mi-
croscopy after light counterstaining with hematoxylin.
Cells exhibiting dark brown staining from the colori-
metric reaction were considered positive for DNA frag-
mentation. Negative controls, conducted by omitting the
labeling enzyme, yielded no reaction product. As positive
controls we used testis samples with abundant apoptosis.
Glutathione analysis
The oxidative stress in the kidney cortex was evaluated
by the measuring the total and free glutathione levels
as previously described [11]. In brief, free sulfhydryls of
thiols were derivatized with monobromobimane to form
fluorescent complexes. Thiols were then separated with
high-performance liquid chromatography (HPLC) and
detected fluorometrically. This gives the concentration
of free thiols. In order to measure the total (reduced +
oxidized) concentration of glutathione, samples of renal
cortex were first treated with dithiothreitol to reduce
disulphides.
Statistics
Data are presented as mean ± standard deviation
(SD). Statistical analyses were carried out using the Stu-
dent t test. Two-tailed P values < 0.05 were considered
significant.
RESULTS
The histology of the 52 NPHS1 kidneys nephrec-
tomized at the age of 4 to 44 months ranged from nearly
normal to severely damaged (Fig. 1A and B). The find-
ings included glomerulosclerosis, interstitial fibrosis and
inflammation, arterial wall thickening, tubular atrophy
and dilatation, and accumulation of proteinaceous mate-
rial into tubular lumen. There was a considerable varia-
tion in the rate of progression of the renal lesions during
the first year as shown by the histologic scoring (Fig. 1C).
Tubular epithelial cell phenotype
Tubular cells contained protein and lipid rich vesi-
cles as studied by high magnification (Fig. 2A). Dilata-
tion of tubules with flattening of epithelial cells was
quite common. Tubular basement membrane ruptures
in PASM staining were seen in 0.4% and 0.5% of the
well-preserved tubuli in NPHS1 and control kidneys, re-
spectively (Table 1) (Fig. 2B to D). Tubular atrophy with
widened tubular basement membrane was often first de-
tected in the vicinity of glomeruli and sharp borders be-
tween the degenerating and healthy tubular profiles were
typically seen (Fig. 2F). The number of apoptotic tubu-
lar cells detected by TUNEL was similar in NPHS1 and
control kidneys (0.04% and 0.06%) (P = NS) (Table 1).
The number of Ki-67–positive proliferating tubular cells
was fourfold in NPHS1 kidneys (0.2% of tubular cells)
as compared to controls (0.05%) (P = 0.07) (Table 1).
The number of tubular epithelial cells with condensed nu-
cleus (apoptosis/mitosis) were 4.4 and 5.5 per 100 tubules
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Fig. 1. Progression of renal damage in NPHS1 kidneys. The histology
of 52 NPHS1 kidneys ranged from nearly normal to severely damaged.
(A) NPHS1 kidney nephrectomized at 4 months showing normal histol-
ogy. (B) Severe lesions are seen in NPHS1 kidneys nephrectomized at
the age of 28 months. Glomerulosclerosis, inflammation, tubular dilata-
tion, and tubulointerstitial fibrosis have evolved. (C) The relationship
between renal damage and age at nephrectomy was studied from kid-
ney samples of 52 NPHS1 patients that were scored based on tubular
cysts, interstitial fibrosis, inflammatory cells, and sclerosed glomeruli.
The rate of progression of damage varies considerably among NPHS1
kidneys (R2 =0.34) [(A and B) periodic acid silver methanamin (PASM)
staining].
in NPHS1 and control kidneys, respectively (P = NS)
(Fig. 2G) (Table 1).
The expression of tubular epithelial cell proteins me-
galin (Fig. 3A to C) and cytokeratin (Figs. 3D to F and
4A) were comparable in control and NPHS1 kidneys
with normal histology (Table 1). Vimentin-positive tubu-
lar cells were present in relatively high numbers, more
in NPHS1 than control kidneys (P < 0.005) (Table 1)
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Fig. 2. Photomicrographs of tubules in NPHS1 patients. (A) Close
view of the walls of two adjacent tubules showing accumulation of pro-
teinaceous material (black) and occasional lipid droplets (white) inside
tubular epithelial cells. (B) Silver staining showing intact tubular base-
ment membranes in tubuli. (C and D) Ruptures of the tubular basement
membrane were very rare and usually associated with interstitial fibrosis
and accumulation of mononuclear inflammatory cells (arrows). (E) In
areas of severe lesions, atrophied tubules were a common finding (encir-
cled by arrows). (F) Tubular atrophy and interstitial fibrosis were first
evident in periglomerular areas and showed a clear-cut change (arrows)
to normal-looking cortical areas. (G) Condensed nuclei speaking for
apoptosis or mitosis of tubular epithelial cells (arrow) were present. (H)
Inflammatory cells were infrequent inside tubules (arrow) and tubulitis
was therefore not a characteristic feature of NPHS1 kidneys [periodic
acid silver methanamin (PASM) stainings].
(Fig. 3I). By contrast, only four possibly a-SMA–positive
tubular cells were found in 651 visual fields (approxi-
mately 117,000 tubular epithelial cells) (Fig. 3L) (Table
1). Similarly, tubular epithelium did not express type I
collagen (Fig. 3O) (Table 1). Immunofluorescence stain-
ing for matrix metalloproteinases 2 and 9 (MMP-2 and
-9) revealed positive cells in interstitium and glomeruli
but very few tubular cells stained for these enzymes
(Fig. 5A and B) (Table 1).
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Table 1. Characteristics of tubular epithelial cells in NPHS1 and control kidneys
Tubular findings NPHS1 Control
Area fraction%a
Megalin
Minor changes 4.5% ± 3.2% 4.6% ± 2.2%
Severe lesions 2.3% ± 1.3% —
Cytokeratin
Minor changes 16.2% ± 7.1% 21.8% ± 5.2%
Severe lesions 15.8% ± 10.4% —
Positive cells/100 tubular
cross-sectionsb
Tubular basement membrane ruptures
Normal morphology 0.37 (2/531) 0.53 (3/570)
Fibrotic interstitium 2.78 (13/468) —
Tubular epithelial cells with condensed nucleus
Normal morphology 2.75 (11/400) 5.5 (11/200)
Fibrotic interstitium 6 (12/200) —
Invading inflammatory cells
Normal morphology 9.03 (27/299) 2.6 (15/577)
Fibrotic interstitium 12.72 (92/723) —
TUNEL 0.48 (69/14400) 0.73 (44/6000)
Ki-67 2.46 (207/8400) 0.69 (25/3600)
a-smooth muscle actin 0.05 (5/8775) 0 (0/990)
Vimentin 127.1 (4920/3870) 40.3 (2000/4965)
Collagen type I 0.08 (5/5940) 0.17 (8/4620)
Matrix metalloproteinase 2 0.26 (6/2325) 0.13 (3/2400)
Matrix metalloproteinase 9 0.4 (14/4500) 0.32 (9/2850)
Transforming growth factor-b 0 (0/4500) 0.37 (11/7300)
TUNEL is terminal deoxynucleotidyl transferase (TdT)-mediated deoxyuridine triphosphate (dUTP) nick end labeling.
aArea fraction results are expressed as mean ± SD of at least four control and at least nine (four minor + five severe lesions) NPHS1 kidneys.
bTubular findings were calculated from at least four control and six NPHS1 kidneys. In parenthesis; number of positive findings/number of tubular cross-sections
analyzed.
Small clusters and solitary cytokeratin-positive cells
were present in the fibrotic interstitium in NPHS1 kid-
neys (Fig. 3F). None of these cells, however, stained for
a-SMA or type I collagen, as studied by double im-
munoperoxidase stainings (500 visual fields analyzed;
data not shown).
Interstitial fibrosis and peritubular capillaries
Interstitial fibrosis was first evident in the vicinity of
glomeruli and sclerotic arteries as well as around de-
generating tubuli (Fig. 6A and B). Due to fibrosis the
peritubular space became progressively wider. Im-
munoperoxidase staining and Western blotting showed
increased amounts of collagen type I and type VI, vi-
mentin, and a-SMA in NPHS1 kidneys as compared con-
trols (Figs. 3G to O and 4B to E). Thickening of arte-
rial and arteriolar walls was evident in NPHS1 kidneys
(Fig. 6A and B). However, the peritubular capillary en-
dothelial surface area was intact as suggested by im-
munoperoxidase staining for the endothelial cell marker
CD34 (Fig. 6C to E). Even so, the peritubular capillary
lumen size was diminished by 47% (Fig. 6F).
Inflammatory cells
Inflammatory cell clusters first appeared in the vicin-
ity of degenerating glomeruli in NPHS1 kidneys (Fig.
7A). The amount of peritubular inflammatory cells was
less pronounced, and it was variable in the fibrotic ar-
eas surrounding the degenerating tubuli. The interstitial
inflammatory cells in the peritubular area were mainly
of the monocyte/macrophage lineage in NPHS1 kidneys
(Fig. 7). The most abundant cells amidst tubuli were
CD14-positive monocyte/macrophages (Fig. 7C and G).
CD3-positive T lymphocytes were the second largest
group of cells in NPHS1 kidneys (Fig. 7D and G). In-
terestingly, tubulitis was not evident (Fig. 2H). Proxi-
mal and distal tubules of NPHS1 and control kidneys
contained comparable numbers of mononuclear cells
(Table 1).
Cytokines and chemokines
The tissue content of 50 cytokines, chemokines, and
some growth factors in the kidney cortex was analyzed
by the cytokine antibody array (Fig. 8). The most signifi-
cant finding was that the signal for neutrophil activating
peptide 2 (NAP-2) in NPHS1 kidneys was 46 times and
14 times stronger than in pig and human controls, re-
spectively. Also, the levels of two monocytic chemokines,
MCP-1 (4.2×), and MIF (3.6×) were clearly elevated.
Other molecules, whose levels in NPHS1 kidney were
clearly elevated as compared to normal pig kidneys, were
angiogenin (10× as compared to pig tissue), intercellu-
lar adhesion molecule-1 (ICAM-1) (4.6×), interleukin
(IL)-1 receptor antagonist (IL-1ra) (3.3×) tumor necrosis
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Fig. 3. Immunoperoxidase staining of tubu-
lar epithelial cell phenotype markers in
NPHS1 kidneys. (A to C) Tubular epithe-
lial cell membrane receptor megalin was ex-
pressed in the same manner and quantity in
NPHS1kidneys with mild changes as in con-
trols. (D to F) The same holds true for the
epithelial cell marker cytokeratin. Small clus-
ters of cytokeratin-positive cells were present
in the fibrotic interstitium [arrow in (F)]. (G)
Mesenchymal marker vimentin was expressed
only in glomerular podocytes in control kid-
neys. (H) Increased vimentin positivity was
seen in NPHS1 kidney interstitium. (I) Many
of the tubular epithelial cells expressed vi-
mentin in NPHS1 kidneys. (J) a-smooth mus-
cle actin (a-SMA) expression was limited to
mesangial cells and blood vessel smooth mus-
cle cells in control kidneys. (K) In the areas
of cortical matrix, the expression of a-SMA
was increased in NPHS1 kidneys. (L) There
were no tubular epithelial cells positive for
a-SMA. (M and N) Increased fibrosis was
present throughout NPHS1 kidneys as seen
by collagen type I staining. (O) There were
no collagen type I expressing tubular epithe-
lial cells.
factor-a (TNF-a) (3×), epidermal growth factor (EGF)
(2.3×), and regulated upon activation, normal T-cell ex-
pressed and secreted (RANTES) (2×).
In immunofluorescence staining the monocytic
chemokine MCP-1 and mono- and lymphocytic cytokine
MIF were mostly detected in interstitial cells and less
so in tubular epithelium (Fig. 5G and H) (Table 1).
Immunofluorescence staining of neutrophilic chemokine
NAP-2 also showed staining in interstitial cells, but, in
addition to this, part of the tubular epithelium expressed
NAP-2 in NPHS1 kidneys (Fig. 5E and F).
The tissue content of the major profibrotic factor, TGF-
b1, was surprisingly low in the cytokine array and did
not significantly differ in NPHS1 and control kidneys
(Fig. 8B). Similarly, the immunoperoxidase staining of
TGF-b revealed no staining of tubuli and a scattered
staining of interstitial cells in NPHS1 kidneys (Table 1).
NPHS1 kidneys contained significantly more VEGF in
the cytokine array compared to controls. The pattern of
immunofluorescence staining was similar to that in con-
trol kidneys (Figs. 6G and H and 8B).
Oxidative stress
The interstitium of NPHS1 kidneys contained numer-
ous MPO-positive foci, as analyzed by immunohisto-
chemistry (Fig. 5D). This prompted us to study the total
amount of oxidative stress in NPHS1 kidneys. As shown
in Figure 9, the concentration of free glutathione was ex-
tremely low in NPHS1 kidney cortex as compared to con-
trols (P < 0.0005) indicating severe oxidative stress. This
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Fig. 4. Western blotting of renal cortex. There was no statistically sig-
nificant difference in cytokeratin (A) or vimentin (C) content between
NPHS1 () and control () kidneys. a-smooth muscle actin (a-SMA)
(B), heat shock protein 27 (HSP27) (F), and collagen type I (D) and VI
(E) were significantly more abundant in NPHS1 kidney cortex than in
controls. Results are expressed as mean ± SD of two independent ex-
periments with samples of four controls and four NPHS1 kidney cortex.
∗∗P < 0.005; ∗∗∗P < 0.0005.
was supported by the finding of high levels of HSP27 in
NPHS1 kidneys as studied by Western blotting (Fig. 4F).
DISCUSSION
We evaluated the tubulointerstitial changes in human
NPHS1 kidneys nephrectomized in the early childhood.
Infiltration of the interstitium by monocytic inflammatory
cells, oxidative stress, and interstitial fibrosis seemed to
be crucial for the progression of the pathologic lesions
in the NPHS1 kidneys. On the other hand, changes in
the peritubular capillaries or phenotypic transition of the
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Fig. 5. Immunohistochemical stainings of some of most interesting sol-
uble factors in NPHS1 kidneys. (A) Matrix metalloproteinase 9 (MMP-
9) was expressed strongly in arterial walls (arrows) of NPHS1 kidneys.
(B) A faint staining of MMP-2 was seen in the glomeruli (arrow) of
NPHS1 kidneys. Neither of the MMPs were expressed in tubular ep-
ithelial cells. (C) Transforming growth factor-b (TGF-b) staining was
strong in interstitial cells (arrows), and no staining was observed in
tubules. (D) Myeloperoxidase (MPO) was abundant in the interstitium
of NPHS1 kidneys. (E) Neutrophil activating protein-2 (NAP-2) stain-
ing was strong in part of the tubules and (F) inflammatory cells. (G
and H) Macrophage inhibiting factor (MIF) and monocyte chemoat-
tractant protein-1 (MCP-1) staining was also seen in inflammatory cells,
but there was no tubular staining [immunofluorescence stainings except
(C) immunoperoxidase].
tubular epithelium did not seem to play a role in this
process.
Large amounts of plasma proteins leak into tubular
lumen and form a heavy burden for the tubular cells in
NPHS1 kidneys. Accordingly, the proximal tubular ep-
ithelial cells were filled with protein and lipid-rich vesi-
cles. The tubular epithelium, however, seemed to be quite
resistant to proteinuria. The rate of apoptosis of tubular
epithelial cells was low, and the proliferative response
was modest, as evaluated by the number of mitotic cells
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E F Fig. 6. Renal vasculature in NPHS1 kidneys.
(A) Arterial wall thickening (arrow) is an
early and prominent feature in NPHS1 kid-
neys and is often accompanied by increased
interstitial matrix formation. (B) Also the ar-
terioles (arrow) are affected as seen here in
the vascular pole of a histologically normal
glomerulus. (C and D) Endothelial marker
CD34 was used to analyze changes in renal
microvasculature. (E) The area fraction% of
CD34 immunoperoxidase staining was simi-
lar in NPHS1 and control kidneys, but (F)
the area fraction of vascular lumens was de-
creased in NPHS1 kidneys compared to con-
trols. Area fractions were measured from five
controls and nine NPHS1 kidneys. (G and H)
Vascular endothelial growth factor (VEGF)
immunofluorescence staining showed that the
expression of VEGF in NPHS1 kidneys was
comparable to controls. ∗P < 0.05; [(A and
B); periodic acid silver methanamin (PASM)
staining].
and the expression of Ki-67. Also, no tubulitis was ob-
served suggesting that urinary proteins did not elicit anti-
genic stimulus. The expression of cytokeratin and me-
galin, which is an important receptor for urinary proteins
in proximal tubular cells [12], was comparable to control
kidneys. These structural findings are supported by the
previous observations that the tubular function in NPHS1
children remain amazingly normal even after months of
massive proteinuria [13, 14]. The NPHS1 children do not
have glucosuria or other signs of proximal tubular defect.
EMT of tubular cells has recently been regarded im-
portant for the progression of renal fibrosis in animal
models [15–17], cell culture works [18–20], and in some
human studies [21–23]. Tubular cells with EMT typically
express a-SMA, actin filaments, vimentin, type I collagen,
fibroblast-specific protein 1 (in mice), and loose epithe-
lial cell markers such as E-cadherin. Some of the trans-
formed cells migrate into peritubular interstitium [15]
and produce interstitial matrix components [17]. Up to
30% of the interstitial myofibroblasts have been reported
to originate from tubular epithelial cells [17]. This migra-
tion requires focal destruction of the tubular basement
membrane which is believed to be accomplished by the
proteolytic enzymes MMP-2 and MMP-9 secreted by the
tubular epithelial cells [5].
We found that a small proportion of the tubular cells
in NPHS1 kidneys expressed vimentin which is in agree-
ment with the findings of Rastaldi et al [21], who found
tubular vimentin in biopsy samples from various human
renal diseases. On the other hand, we found practically no
tubular cells positive for a-SMA, type I collagen, MMP2,
or MMP9. Also, no cells coexpressing cytokeratin and
a-SMA or type I collagen were detected in the intersti-
tium. The findings were based on the analysis of hundreds
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Fig. 7. Light microscopy and immunoperoxidase staining of inflamma-
tory cells in the tubulointerstitium of NPHS1 and control kidneys. (A
to F) NPHS1 kidneys. (A) Inflammatory cell infiltration first appeared
in the vicinity of degenerating glomeruli. (B) Solitary and small clusters
of inflammatory cells were also evident in the interstitium. The most
abundant inflammatory cells in the NPHS1 kidney interstitium were
(C) monocytes, (D) T lymphocytes, (E) B lymphocytes, and (F) neu-
trophils. (G) Graph showing positive interstitial cells per visual field.
Positive cells from at least 50 visual fields (200×) were counted from
each of the seven NPHS1 and four control kidneys. Cells located among
tubuli were calculated. Large infiltrates located at periglomerular or to-
tally damaged areas were excluded from these calculations [(A and B)
periodic acid silver methanamin (PASM) staining].
of visual fields and strongly suggest that tubular cells in
NPHS1 kidneys do not undergo EMT. Since kidneys from
young individuals show the highest plasticity, one would
expect to detect EMT especially in infant kidneys with
proteinuria.
Several cytokines and growth factors are known to pro-
mote EMT. TGF-b1 is reported to be able to complete
the entire EMT process in vitro [24, 25]. A surprising
finding in this study was that NPHS1 kidneys had the
same levels of TGF-b1 as human and pig control kidneys
in the cytokine array. The immunohistochemical staining
revealed few scattered TGF-b1–positive cells in the in-
terstitium but not in the tubular epithelium. Interestingly,
the level of hepatocyte growth factor (HGF), which neg-
atively modulates EMT [26], was decreased in NPHS1
kidneys.
Chemokines are believed to play an important role
in renal fibrosis by attracting inflammatory cells into
the interstitium. Tubular epithelial cells possibly pro-
duce chemokines in the early phase [27, 28], but later
on they may originate from the infiltrating inflammatory
cells [29–31]. MCP-1 is regarded as the most important
chemokine in this context. It attracts leukocytes and is
involved in the initiation and progression of tubuloint-
erstitial damage [32, 33]. Another interesting chemokine
with similar effects is MIF [34]. In NPHS1 kidneys, the
tissue levels of both chemokines were clearly elevated
but there were no tubular cell staining in immunoflu-
orescence. Surprisingly, very high level of NAP-2 were
present in NPHS1 kidneys, and immunofluorescence re-
vealed NAP-2 expression both in tubular and intersti-
tial cells. NAP-2 is one of the b-thromboglobulin (b-TG)
proteins produced by many cell types. It preferentially
attracts neutrophils and stimulates lysosomal enzyme de-
granulation in these cells [35], but its role in renal diseases
is so far unknown.
Monocyte/magrophages and T lymphocytes were the
most abundant inflammatory cells in NPHS1 kidneys.
This is in agreement with the result obtained in mice
[36] and also in human kidneys [37, 38]. The role of
macrophages in chronic renal failure has been em-
phasized. They may secrete fibrosis-promoting growth
factors (e.g., TGF-b) and vasoactive products (e.g.,
endothelin-1, angiotensin II) and participate in the re-
cruitment of the matrix-producing interstitial myofibrob-
lasts [39].
The loss of peritubular microvasculature and subse-
quent ischemia has also been reported to play a major
role in tubulointerstitial scarring [40]. In NPHS1 kidneys
the peritubular capillaries looked narrower than in the
control kidneys, but no decrease of the capillary endothe-
lium was seen in the CD34 staining. Also, the endothelial
survival factor VEGF was abundantly expressed in the
tubulointerstitium of NPHS1 kidneys, as shown by the
cytokine array and immunohistochemistry. Thus, loss of
peritubular capillaries clearly does no explain the fibrotic
process.
The interstitial expression of MPO was strong in
the NPHS1 kidneys. This enzyme was mainly produced
and secreted by monocyte/macrophages as shown by
the double immunofluorescence stainings and reported
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Fig. 8. Antibody array analysis of cytokines, chemokines, and other mediators in NPHS1 kidney cortex. The most abundant mediators are shown as
bars and the ones with levels near the detection limit of the array are only mentioned in the box. (A) Cytokines. Note the extremely high amount of
neutrophil activating protein-2 (NAP-2) in NPHS1 kidneys compared to controls. Also the levels of macrophage inhibiting factor (MIF), monocyte
chemoattractant protein-1 (MCP-1), interleukin-1 receptor antagonist (IL-1ra), regulated upon activation, normal T-cell expressed and secreted
(RANTES), and tumor necrosis factor-a (TNF-a) were higher in NPHS1 than in controls. (B) Growth factors and other mediators. Intercellular
adhesion molecule-1 (ICAM-1), epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), and angiogenin levels were higher in
NPHS1 kidneys compared to controls. The levels of the major profibrotic factor transforming growth factor-b (TGF-b) were not elevated in NPHS1
kidneys. Hepatocyte growth factor (HGF) levels were lower in NPHS1 kidneys than in controls. (C) The most interesting cytokines and growth
factors in NPHS1 kidneys divided to two groups based on histologic score. Results are expressed as mean of 10 NPHS1, seven control human and
three control pig kidney cortex samples in (A) and (B). In (C) the results are expressed as mean ± SD of four NPHS1 kidneys with minor and of
six kidneys with severe lesions.
previously in human diseases [41]. MPO generates a pow-
erful oxidant, hypoclorous acid (HOCl), which may cause
permanent tissue damage [42]. The importance of MPO
and other possible oxidants was supported by the find-
ing of very low levels of free glutathione in the cortex
of NPHS1 kidneys. Glutathione is a major antioxidant
in human tissues and the amount of free glutathione de-
creases in the presence of HOCl and other reactive oxy-
gen species [42]. The high levels of the scaffold protein
HSP27 also support the idea that NPHS1 kidneys are un-
der heavy oxidative stress [43].
CONCLUSION
The results in this work suggest that the tubular
epithelium is quite resistant to proteinuria. We did
not find diffuse tubular atrophy, which would have
been caused by the direct toxicity of luminal pro-
teins. Instead, tubular atrophy was associated with in-
terstitial fibrosis and inflammation, which often was
periglomerular and segmental at first. Thus, the dele-
terious effect of proteinuria seems to be indirect and
mediated by the peritubular fibrotic and inflammatory
process.
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